A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.
about
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents5-Azacytidine enhances the radiosensitivity of CNE2 and SUNE1 cells in vitro and in vivo possibly by altering DNA methylationEpigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomasCombination effect of epigenetic regulation and ionizing radiation in colorectal cancer cellsEvaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaksDNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating studyIn vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancerDNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activityEnhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugsThe combination effect of sodium butyrate and 5-Aza-2'-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell linesThe Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells.HDAC inhibitor-based therapies: can we interpret the code?DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients: new diagnostic approaches and treatment.Epigenetics in radiation-induced fibrosis.Epigenetic DNA methylation in radiation biology: on the field or on the sidelines?Histone deacetylase inhibitors in oral squamous cell carcinoma treatment.Decitabine: a promising epi-immunotherapeutic agent in solid tumors.DNA methylation profiles in cancer diagnosis and therapeutics.Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.Enhancement of radiosensitivity by 5-Aza-CdR through activation of G2/M checkpoint response and apoptosis in osteosarcoma cells.FLT1 kinase is a mediator of radioresistance and survival in head and neck squamous cell carcinoma.Role of DNA methylation in long-term low-dose γ-rays induced adaptive response in human B lymphoblast cells.Combinatorial effects of an epigenetic inhibitor and ionizing radiation contribute to targeted elimination of pancreatic cancer stem cell.Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance.
P2860
Q21198868-49B48D27-4300-4D63-9E03-D5608B636276Q27312329-0D80306D-942F-4D3D-ADAA-2A509B2ED04BQ33742171-E46C3B3E-44A9-46C4-ACFF-A25EE7A93D77Q34066595-C14A208E-D6DF-40FC-868F-D8888C19A2E4Q34567095-4B891EEC-DBFC-44AA-90BE-A7ADE439699DQ35176178-64F6A613-90AA-4114-A7C8-374B1F81F15EQ35870855-755EB7B3-231D-420D-91D4-82CBAA0D1000Q36032155-4CF1FDFE-628B-4895-89DC-B9567C997BBFQ37018003-63DC3FF8-8DC7-4F97-AF36-ED586A87FD09Q37218548-BCA1595C-6A88-408D-B25D-C202DDF528EFQ37690270-A49224DB-2BA7-4C0A-941C-41F14F907F0EQ38058971-0777FC6B-A956-4106-9C51-8D4FE3DB580FQ38119172-78E0430E-0F31-4C55-9C44-6D6EEB3CD9C3Q38218535-52F5A28C-3E3E-48B8-AD07-101A5CE6C3C3Q38245899-AAE5D1CC-062F-477C-BD85-613F91FEC8CBQ38248710-AB2D9A24-696D-4369-878B-E72F0ED3220AQ38314204-FE080FD1-BAF2-4C5F-A29F-BB849D71D848Q38650593-A5405868-A056-4F67-9857-8D453A4BE586Q38761174-F35ABE6F-4A07-47E6-B685-DB459BA86129Q38845317-19F4D2B2-B5D8-40A6-ADC1-C5274C07FC35Q39029463-CD8E946D-4613-453C-B01B-349CB96A3612Q39095142-D5DC4AD2-6DC7-46B9-81DE-111E4A8C347CQ39149195-D740AAFF-17FD-4398-919D-3E8BF486AF77Q47096734-0E5CD1F3-A686-437A-A536-8FE7EC4C418DQ53270993-8389E82F-7EFB-4AC1-A7BC-CD4542F543D7
P2860
A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A systematic assessment of rad ...... -neck squamous cell carcinoma.
@en
A systematic assessment of rad ...... -neck squamous cell carcinoma.
@nl
type
label
A systematic assessment of rad ...... -neck squamous cell carcinoma.
@en
A systematic assessment of rad ...... -neck squamous cell carcinoma.
@nl
prefLabel
A systematic assessment of rad ...... -neck squamous cell carcinoma.
@en
A systematic assessment of rad ...... -neck squamous cell carcinoma.
@nl
P2093
P1476
A systematic assessment of rad ...... d-neck squamous cell carcinoma
@en
P2093
Harlinde De Schutter
Marlies Kimpe
Sofie Isebaert
P304
P356
10.1016/J.IJROBP.2008.10.032
P407
P50
P577
2009-03-01T00:00:00Z